External Resource
MontagCOGROctober2016_reThursdayPMv
Johns Hopkins Technology Ventures (JHTV) serves as the central entity for technology commercialization at Johns Hopkins University, aiming to translate the institution's extensive research achievements into accessible products, services, and technologies that benefit society. As a national leader in research funding—with more than $1.95 billion from the NIH, and a distinguished history of Nob
NEUMANN_SLIDE_PRESENTATION_ON_RESEARCH_REQUIREMENTS_REPORT
The GAO conducted a review of federal research grants in response to concerns expressed by the House Committee on Science, Space, and Technology about the significant administrative workload—estimated at 42%—faced by universities in managing these grants. Focusing on four key federal agencies (DOE, NASA, NIH, and NSF) and a selection of research institutions, the report examined the origins and ob
Research Regulation Committee Briefing Slides COGR 10-20-16
The document "Optimizing the Nation’s Investment in Academic Research: A New Regulatory Framework for the 21st Century," prepared by the Committee on Federal Research Regulations and Reporting Requirements under the National Academy of Sciences, addresses the increasingly complex federal regulatory environment facing U.S. academic research institutions. It asserts that while regulations
How_to_Conduct_Non-Federal_Stem_Cell_Research_Without_Violating_the_Federal_Stem_Cell_Funding_Prohibition
The article by Robert J. Kenney Jr. addresses how federally funded research institutions can conduct research involving human embryonic stem cells (hESC) without violating the prohibition on federal funding for such research, as set by the Bush administration in 2001. This prohibition, which limits the use of federal funds to research involving only certain pre-approved hESC lines, has created cha
Institute_of_Medicine_Research_Integrity_Report_Analysis
The Institute of Medicine’s report, produced at the request of the Department of Health and Human Services’ Office of Research Integrity, examines how research institutions can cultivate environments that foster integrity in scientific research. The Committee asserts that promoting research integrity cannot rely solely on regulatory compliance or federal mandates, but must instead arise from a per
NSDD_Directive_189
NSDD Directive 189, issued on September 21, 1985, establishes U.S. national policy regarding the dissemination of scientific, technical, and engineering information stemming from federally funded fundamental research at academic and research institutions. The directive distinguishes "fundamental research" as basic or applied research whose results are typically published and widely share
Letter_from_National_Security_Advisor_to_CSIS_
The letter, dated November 1, 2001, from National Security Advisor Condoleeza Rice to Dr. Harold Brown of the Center for Strategic & International Studies, addresses concerns raised by the Council on the Future of Technology and Public Policy regarding export controls and their impact on fundamental scientific research. Rice acknowledges the pivotal role of open and collaborative basic researc
Approaches_to_Developing_an_Institutional_Conflict_of_Interest_Policy_-_Section_Six
Section Six of the COGR document "Approaches to Developing an Institutional Conflict of Interest Policy" provides a curated resource bibliography and comprehensive list of links to institutional and federal policies relevant to the development of conflict of interest (COI) policies at universities and research organizations. The primary focus is on institutional financial conflicts of in
Bailey_Presentation_Thursday_Morning_June_2015
The presentation by Matthew R. Bailey, Executive Vice President of the National Association for Biomedical Research (NABR), outlines the current landscape of public policy and regulatory challenges surrounding animal research at universities. NABR, advocating for humane animal research for over 35 years, has been instrumental in supporting legislation such as the Animal Enterprise Terrorism Act (A
Buroughs_Presentation_Thursday_Afternoon_June_2015
The document, authored by Lizbet Boroughs and presented on behalf of the American Association of Universities, provides an overview and critical analysis of Title I—NIH provisions—of the 21st Century Cures Act (HR 6) as of June 2015. The Act is recognized for bolstering momentum for increased support and funding for the National Institutes of Health (NIH), asserting biomedical research as a nation
